VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Nov 12, 2024 9:58am

39 Views

Post# 36308110

RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

Ventripoint Diagnostics Ltd.'s next-gen cardiac imaging system has been approved for use in EU and Canada (FDA reviewing). It provides more accurate cardiac output data for echo images. Automated, fast and easy to integrate into workflows.

Existing users include Duke, Sick Kids, Seattle Children's, Vienna Children's, East Midlands, Evalina and German Heart Center.

cardiology AI echofirst cardiovascular